Correlation Between Target Global and Phoenix Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Target Global and Phoenix Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Target Global and Phoenix Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Target Global Acquisition and Phoenix Biotech Acquisition, you can compare the effects of market volatilities on Target Global and Phoenix Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Target Global with a short position of Phoenix Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Target Global and Phoenix Biotech.

Diversification Opportunities for Target Global and Phoenix Biotech

0.34
  Correlation Coefficient

Weak diversification

The 3 months correlation between Target and Phoenix is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Target Global Acquisition and Phoenix Biotech Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phoenix Biotech Acqu and Target Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Target Global Acquisition are associated (or correlated) with Phoenix Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phoenix Biotech Acqu has no effect on the direction of Target Global i.e., Target Global and Phoenix Biotech go up and down completely randomly.

Pair Corralation between Target Global and Phoenix Biotech

If you would invest  1,126  in Target Global Acquisition on September 16, 2024 and sell it today you would earn a total of  10.00  from holding Target Global Acquisition or generate 0.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy1.54%
ValuesDaily Returns

Target Global Acquisition  vs.  Phoenix Biotech Acquisition

 Performance 
       Timeline  
Target Global Acquisition 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Target Global Acquisition are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Target Global is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Phoenix Biotech Acqu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Phoenix Biotech Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Phoenix Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Target Global and Phoenix Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Target Global and Phoenix Biotech

The main advantage of trading using opposite Target Global and Phoenix Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Target Global position performs unexpectedly, Phoenix Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phoenix Biotech will offset losses from the drop in Phoenix Biotech's long position.
The idea behind Target Global Acquisition and Phoenix Biotech Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets